Instagram on MSN

2026’s IPO lineup is getting dangerous

IPOs are lining up for 2026, and the rush could reset valuations overnight. Here’s what to watch before the crowd shows up.
GlobalData on MSN

Aktis Oncology kicks 2026 IPO cycle off with $210m target

According to the registration form, Aktis intends to use a large portion of the IPO proceeds on the two programmes. Around ...